MedTrace Logo

PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load

NCT02158221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2015-02-10

No results posted yet for this study

Summary

The investigators hypothesized that migraine without patients with many genetic loci associated with migraine (high genetic load) would be more sensitive and get provoked more migraine attacks by PACAP compared to patients with few genetic loci associated with migraine (low genetic load).

Conditions

  • Migraine Without Aura

Interventions

DRUG

PACAP

Pituitary adenylate cyclase-activating polypeptide (PACAP)

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2014-11-30
Completion
2014-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02158221 on ClinicalTrials.gov